Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00174486
Status:
COMPLETED
Last Update Posted:
2006-07-25
First Post:
2005-09-12
Brief Title:
Assessment Of Duration Of Action Safety Toleration Of UK369003 and Cialis In Patients With Erectile Dysfunction
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Double Blind Placebo Controlled Parallel Group Multicenter Study To Assess The Duration Of Action Safety And Toleration Of Differing Doses and Combinations Of Immediate and Modified Release Formulations Of UK-369003 and Cialis Compared To Placebo In Adult Male Subjects With Erectile Dysfunction
Status:
COMPLETED
Status Verified Date:
2005-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Assessment of duration of action safety toleration of different formulations and doses of UK-369003 and Cialis in patients with male erectile dysfunction Patients should have previously been on PDE5 inhibitors and have been respondents to the drug Duration of treatment is 4 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None